selected scholarly activity
-
conferences
- Clinical Delineation of Myasthenia Gravis in the Kingdom of Bahrain. Neurology. 2022
- Clinical Delineation of Myasthenia Gravis in the Kingdom of Bahrain. Neurology. 2022
-
journal articles
- Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. Frontiers in Neurology. 15:1366263. 2024
- Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Family Planning within the Management of MS. Clinical and Translational Neuroscience. 7:10-10. 2023
- Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Diagnosis and Radiology/Imaging. Clinical and Translational Neuroscience. 7:5-5. 2023
- Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination. Clinical and Translational Neuroscience. 7:6-6. 2023
- Discussing the potential for progression with patients newly diagnosed with multiple sclerosis: When, how, and why?. Multiple Sclerosis and Related Disorders. 68:104230-104230. 2022
- Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses. Clinical and Translational Neuroscience. 6:27-27. 2022
- Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD). Multiple Sclerosis and Related Disorders. 66:104062-104062. 2022
- Saudi consensus recommendations on the management of multiple sclerosis: MS management in children and adolescents. Multiple Sclerosis and Related Disorders. 66:104061-104061. 2022
- Clinical delineation of myasthenia gravis in the Kingdom of Bahrain. Neurosciences. 27:16-23. 2022
- Clinical and genetic features of Calpainopathies in Saudi Arabia - a descriptive cross-sectional study.. European Review for Medical and Pharmacological Sciences. 25:4941-4952. 2021
- Blood pressure changes during alemtuzumab infusion for multiple sclerosis patients. European Journal of Neurology. 28:1396-1400. 2021
- Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know. Neurology and Therapy. 9:11-23. 2020
- Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry. Multiple Sclerosis and Related Disorders. 38:101448-101448. 2020
- Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum. Frontiers in Neurology. 11:89. 2020
- Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 6:205521731985019-205521731985019. 2020
- Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis. Frontiers in Pediatrics. 8:339. 2020
- Disease-modifying therapies should be stopped in NMOSD patients in remission – Yes. Multiple Sclerosis. 25:1217-1218. 2019
- Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology. Neurology. 93:e414-e420. 2019
- Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurology. 76:301-301. 2019
- Area postrema syndrome. Neurology. 91:e1642-e1651. 2018
- CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes. Clinical Chemistry and Laboratory Medicine. 56:1071-1080. 2018
- Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache. Pain Research and Treatment. 2018:1-6. 2018